DUSP26 and neuroblastoma: DUSP26 inhibition with a small-molecule inhibitor NSC-87877 or shRNA targeting DUSP26 was shown to decrease proliferation and cell viability in neuroblastoma cell lines by activation of p53 and p38 MAPK tumor suppressor pathways [24].